Clinical Trials Browser

Phase 2 × pegamotecan × Gastrointestinal × Clear all

NCT00080002 2012-09-06

Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction

Phase 2 Terminated

Gastrointestinal

Neoplasms, Stomach Neoplasms